How do the costs of biological weapons compare to other types of weapons?

Biological agents are known to be several hundred times less expensive than conventional weapons, which is a significant factor in their potential use as weapons of mass destruction. The low cost of production and development of biological agents makes them an attractive option for those seeking to inflict harm or cause disruption without the extensive financial burden typically associated with conventional arms.

This affordability allows for widespread access, enabling even non-state actors to potentially acquire and deploy them. Moreover, the impact of biological agents can be extensive because they can cause disease that spreads through populations, leading to widespread effects that far exceed their initial monetary investment. This factor underscores the critical importance of understanding and mitigating the threat posed by biological weapons in disaster nursing and public health preparedness.